Case Report: Anti-MOG Antibody Seroconversion Accompanied by Dimethyl Fumarate Treatment

Overview of attention for article published in Frontiers in immunology, February 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 34,352 followers.

RT @FrontImmunol: New Research: Case Report: Anti-MOG Antibody Seroconversion Accompanied by Dimethyl Fumarate Treatment: Here we report th…

23 Mar 2021

Reply Repost Favourite

New Research: Case Report: Anti-MOG Antibody Seroconversion Accompanied by Dimethyl Fumarate Treatment: Here we report three cases of anti-myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD) mimicking multiple… https://t.co/iKYcqj

22 Mar 2021

Reply Repost Favourite

Case Report: Anti-MOG Antibody Seroconversion Accompanied by Dimethyl Fumarate Treatment https://t.co/8hIK04Tge8

04 Mar 2021

Reply Repost Favourite

Case Report: Anti-MOG Antibody Seroconversion Accompanied by Dimethyl Fumarate Treatment https://t.co/9K6iyij87j

04 Mar 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.